Genomics is set to grow exponentially as an industry. There are several sub categories within this industry including consumer genomics, agrigenomics, digital cytogenomics.
Bionano Genomics (BNGO) revenues are due to explode in years to come. Analysts predicting over 100% + upside in the next 12 months. With an overall rating of buy/ strong buy.
I’ve been covering this company for around 6 months, it’s gone from $0.50 to $15.69, but I believe in 5-8 years we will see the full scope and bigger picture in terms of global adoption for their saphyr machine/ increased sales/ increased revenue.
They currently are being used by some russell group/ major research institutions and hospitals like Kings College Hospital London/ Harvard University. Several russell group universities actually use the Saphyr. I’ve been buying each week as soon as my paycheck hits. Price prediction is $100/ share in 5-8 years.
Not financial advice: